|
|
|
|
|
|
|
|
||||||
Review articles
Molecular medicine of microRNAs: structure, function and implications for
diabetes
Erica
Hennessy and Lorraine O'Driscoll
Abstract
Published 15th
August 2008
New molecular targets in angiogenic vessels of glioblastoma tumours
Joshua
C. Anderson, Braden C. McFarland and Candece L. Gladson
Abstract
Published 7th
August 2008
Critical molecular abnormalities in high-grade serous carcinoma of the ovary
Martin
Köbel, David Huntsman and C. Blake Gilks
Abstract
Published 1st
August 2008
Molecular
pathogenesis and clinical implications of eczema herpeticum
Caroline
Bussmann, Wen-Ming Peng, Thomas Bieber and Natalija Novak
Abstract
Published 14th
July 2008
CD1d-restricted
glycolipid antigens: presentation principles, recognition logic and functional
consequences
William
C. Florence, Rakesh K. Bhat and Sebastian Joyce
Abstract
Published 7th
July 2008
p21
and p27: roles in carcinogenesis and drug resistance
Abde
M. Abukhdeir and Ben Ho Park
Abstract
Published 1st
July 2008
Therapeutic immunomodulators from nematode parasites
William
Harnett and Margaret M. Harnett
Abstract
Published 19th
June 2008
Galectins: structure, function and therapeutic potential
Ri-Yao
Yang, Gabriel A. Rabinovich and Fu-Tong Liu
Abstract
Published 13th
June 2008
Advances in mouse models of prostate cancer
Imran
Ahmad, Owen J. Sansom and Hing Y. Leung
Abstract
Published 9th
June 2008
Mechanisms
in allergic airway inflammation – lessons from studies in the mouse
Bennett
O.V. Shum, Michael S. Rolph and William A. Sewell
Abstract
Published 27th
May 2008
The
molecular and cellular defects underlying Pelizaeus–Merzbacher disease
Karen
J. Woodward
Abstract
Published 19th
May 2008
Mammalian aquaporins: diverse physiological roles and potential clinical
significance
A.
S. Verkman
Abstract
Published 16th
May 2008
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection
Theodore
C. Pierson and Michael S. Diamond
Abstract
Published 12th
May 2008
Wound healing and local neuroendocrine regulation in the injured liver
Mohammad
R. Ebrahimkhani, Ahmed M. Elsharkawy and Derek A. Mann
Abstract
Published 29th
April 2008
Interrogating
the genome to understand oestrogen-receptor-mediated transcription
Sara
C. Dietz and Jason S. Carroll
Abstract
Published 1st
April 2008
Molecular
pathogenesis of intrahepatic cholestasis of pregnancy
Marco
Arrese, Rocio I.R. Macias, Oscar Briz, Maria J. Perez and Jose J.G. Marin
Abstract
Published 28th
March 2008
Protein–protein
interactions as targets for small-molecule therapeutics in cancer
Alex
W. White, Andrew D. Westwell and Ghali Brahemi
Abstract
Published 19th
March 2008
Molecular
mechanisms and treatment of bone metastasis
Gregory
A. Clines and Theresa A. Guise
Abstract
Published 6th
March 2008
BRAF kinase in melanoma development and progression
Amena
M. DeLuca, Archana Srinivas and Rhoda M. Alani
Abstract
Published 18th
February 2008
Rotavirus
vaccines: how they work or don't work
Richard
L. Ward
Abstract
Published 12th
February 2008
Mammalian
target of rapamycin (mTOR) pathway signalling in lymphomas
Elias
Drakosa, George Z. Rassidakisa and L. Jeffrey Medeiros
Abstract
Published 4th
February 2008
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical
implications
Evanthia
Diamanti-Kandarakis
Abstract
Published 30th
January 2008
Targeting
of the immune system in systemic lupus erythematosus
Meera
Ramanujam and Anne Davidson
Abstract
Published 21st
January 2008
The mucopolysaccharidoses: a success of molecular medicine
Lorne
A. Clarke
Abstract
Published 18th
January 2008
2007
Virulence
factors in brucellosis: implications for aetiopathogenesis and treatment
Emilie
Fugier, Georgios Pappas and Jean-Pierre Gorvel
Abstract
Published 19th
December 2007
Antibody-based
immunotherapy in high-risk neuroblastoma
Erik
Johnson, Shannon M. Dean and Paul M. Sondel
Abstract
Published 17th
December 2007
Iron-regulatory proteins: molecular biology and pathophysiological implications
Gaetano
Cairo and Stefania Recalcati
Abstract
Published 5th
December 2007
Pathogenesis of infantile haemangioma: new molecular and cellular insights
Matthew
R. Ritter, Ross A. Butschek, Martin Friedlander and Sheila F. Friedlander
Abstract
Published 29th
November 2007
Stem
cell ageing: does it happen and can we intervene?
Ilaria
Bellantuono and W. Nicol Keith
Abstract
Published 19th
November 2007
New
targeted therapies for treatment of thrombosis in antiphospholipid syndrome
Silvia
S. Pierangeli, Mariano E. Vega-Ostertag and Emilio B. González
Abstract
Published 13th
November 2007
Haematopoietic
stem cell transplantation: can our genes predict clinical outcome?
Anne
M. Dickinson, Jane L. Harrold and Hannah Cullup
Abstract
Published 2nd
November 2007
Targeting
the lipids LPA and S1P and their signalling pathways to inhibit tumour progression
Mandi
Murph and Gordon B. Mills
Abstract
Published 15th
October 2007
The
molecular pathogenesis of Paget disease of bone
Robert
Layfield
Abstract
Published 1st
October 2007
Holoprosencephaly:
new models, new insights
Robert
S. Krauss
Abstract
Published 24th
September 2007
Charcot–Marie–Tooth
type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases
Stefano
C. Previtali, Angelo Quattrini and Alessandra Bolino
Abstract
Published 20th
September 2007
Autism: the quest for the genes
Nuala
H. Sykes and Janine A. Lamb
Abstract
Published 3rd
September 2007
Rubinstein–Taybi
syndrome: clinical and molecular overview
Jeroen
H. Roelfsema and Dorien J.M. Peters
Abstract
Published 20th
August 2007
Congenital
myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission
Juliane
S. Müller, Violeta Mihaylova, Angela Abicht and Hanns Lochmüller
Abstract
Published 9th
August 2007
Molecular
cell biology of KATP channels: implications for neonatal diabetes
Andrew
J. Smith, Tarvinder K. Taneja, Jamel Mankouri and Asipu Sivaprasadarao
Abstract
Published 1st
August 2007
Molecular targets for disrupting leukocyte trafficking during multiple sclerosis
Erin
E. McCandless and Robyn S. Klein
Abstract
Published 19th
July 2007
Norovirus–host interaction: implications for disease control and prevention
Ming
Tan and Xi Jiang
Abstract
Published 11th
July 2007
Salmonella-induced
enteritis: molecular pathogenesis and therapeutic implications
Abigail
N. Layton and Edouard E. Galyov
Abstract
Published 2nd
July 2007
Novel
therapeutic strategies for the treatment of protein-misfolding diseases
Jean-Christophe
Rochet
Abstract
Published 28th
June 2007
Chemical
and pharmacological chaperones as new therapeutic agents
Tip
W. Loo and David M. Clarke
Abstract
Published 28th
June 2007
Rearrangements of the Williams–Beuren syndrome locus: molecular basis and
implications for speech and language development
Lucy
R. Osborne and Carolyn B. Mervis
Abstract
Published 13th
June 2007
The
role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis
Suzie
Ariyaratana and David M. Loeb
Abstract
Published 24th
May 2007
The
heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms
Honami
Naora
Abstract
Published 4th
May 2007
Nasopharyngeal
carcinoma: molecular pathogenesis and therapeutic developments
Qian
Tao and Anthony T.C. Chan
Abstract
Published 4th
May 2007
Congenital
adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
João
Gonçalves, Ana Friães and Luís Moura
Abstract
Published 30th
April 2007
Immunology
of pregnancy: cellular mechanisms allowing fetal survival within the maternal
uterus
Ana
Claudia Zenclussen, Anne Schumacher, Maria Laura Zenclussen, Paul Wafula
and Hans-Dieter Volk
Abstract
Published 27th
April 2007
Atopic dermatitis:
insights from linkage overlap and disease co-morbidity
Saffron
A.G. Willis-Owen, Nilesh Morar and Charles A. Willis-Owen
Abstract
Published 3rd
April 2007
The therapeutic
potential of gene transfer for the treatment of peripheral neuropathies
James
R. Goss
Abstract
Published 19th
March 2007
Epigenetic
control of cellular senescence in disease: opportunities for therapeutic
intervention
Stuart
P. Atkinson and W. Nicol Keith
Abstract
Published 13th
March 2007
Molecular
mechanisms of HIV integration and therapeutic intervention
Nick
Vandegraaff and Alan Engelman
Abstract
Published 26th
February 2007
Serotonin
and energy balance: molecular mechanisms and implications for type 2 diabetes
Daniel
D. Lam and Lora K. Heisler
Abstract
Published 22nd
February 2007
Immunological
responses can have both pro- and antitumour effects: implications for immunotherapy
Trina
J. Stewart, Kristy M. Greeneltch, M.E. Christine Lutsiak and Scott I. Abrams
Abstract
Published 7th
February 2007
Age-related
changes in immunity: implications for vaccination in the elderly
Rania
D. Kovaiou, Dietmar Herndler-Brandstetter and Beatrix Grubeck-Loebenstein
Abstract
Published 1st
February 2007
Endometriosis:
disease pathophysiology and the role of prostaglandins
Meng-Hsing
Wu, Yutaka Shoji, Pei-Chin Chuang and Shaw-Jenq Tsai
Abstract
Published 16th
January 2007
The
peanut allergy epidemic: allergen molecular characterisation and prospects
for specific therapy
Maria
P. de Leon, Jennifer M. Rolland and Robyn E. O'Hehir
Abstract
Published 9th
January 2007
2006
Post-lactational
mammary gland regression: molecular basis and implications for breast cancer
Christine
J. Watson
Abstract
Published 20th
December 2006
Mechanisms
of serpin dysfunction in disease
by
Dion Kaiserman, James C. Whisstock and Phillip I. Bird
Abstract
Published 11th
December
2006
Tumour–host
interactions: implications for developing anti-cancer therapies
by
Bedrick B. Gadea and Johanna A. Joyce
Abstract
Published 11th
December
2006
Molecular
mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity?
by
Robert H. Swanborg, Dov L. Boros, Judith A. Whittum-Hudson and Alan P. Hudson
Abstract
Published 30th
November
2006
The
interaction of macrophage receptors with bacterial ligands
by
Annette Plüddemann, Subhankar Mukhopadhyay and Siamon Gordon
Abstract
Published 22nd
November
2006
Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human
genetic studies
by
Francis Vasseur, David Meyre and Philippe Froguel
Abstract
Published 20th
November
2006
Refractory
juvenile idiopathic arthritis: using autologous stem cell transplantation
as a treatment strategy
by
Nico M. Wulffraat, Ismé M. de Kleer and Berent Prakken
Abstract
Published 15th
November
2006
Crystallins
and hereditary cataracts: molecular mechanisms and potential for therapy
by
Usha P. Andley
Abstract
Published 19th
October
2006
Molecular
basis of inherited skin-blistering disorders, and therapeutic implications
by
Monique Aumailley, Cristina Has, Lucy Tunggal and Leena Bruckner-Tuderman
Abstract
Published 13th
October
2006
ErbB
receptors and their ligands in the breast
by
Cynthia A. Zahnow
Abstract
Published 19th
September
2006
GATA
factors in vertebrate heart development and disease
by Alison
Brewer and John Pizzey
Abstract
Published 18th September
2006
Interactions
between respiratory syncytial virus and the host cell: opportunities for
antivirus strategies?
by Richard J. Sugrue
Abstract
Published 7th September
2006
Tryptophan
metabolism in the central nervous system: medical implications
by Jon P. Ruddick, Andrew K. Evans, David J. Nutt, Stafford L. Lightman,
Graham A.W. Rook and Christopher
A. Lowry
Abstract
Published 31st August
2006
Elastic
fibres in health and disease
by Cay M. Kielty
Abstract
Published 8th August
2006
Claudins:
emerging targets for cancer therapy
by Scott L. Kominsky
Abstract
Published 4th August
2006
Beckwith–Wiedemann
syndrome: multiple molecular mechanisms
by Thorsten Enklaar, Bernhard U. Zabel and Dirk Prawitt
Abstract
Published 17th July
2006
Preclinical applications of imaging for cancer gene therapy
by Arnaud
Briat and Georges Vassaux
Abstract
Published 14th July
2006
STAT
signalling in the heart and cardioprotection
by Surinder
M. Soond, David S. Latchman and Anastasis Stephanou
Abstract
Published 12th July
2006
Alopecia
areata: pathogenesis and potential for therapy
by Wei
Lu, Jerry Shapiro, Mei Yu, Armin Barekatain, Blanche Lo, Andreas Finner
and Kevin McElwee
Abstract
and features
Published 20th June
2006
Molecular biology of Rh proteins and relevance to molecular medicine
by Neil D. Avent, Tracey E. Madgett, Zoe E. Lee, David J. Head, Deborah
G. Maddocks and Lucy H. Skinner
Abstract
and features
Published 12th June
2006
Implications
of reproductive technologies for birth and developmental outcomes: imprinting
defects and beyond
by Ariane Paoloni-Giacobino
Abstract
and features
Published 5th June
2006
Amyotrophic lateral sclerosis (motor neuron disease): proposed
mechanisms and pathways to treatment
by Emily F. Goodall and Karen E. Morrison
Abstract
and features
Published 24th May
2006
Pathophysiology
and therapy for haemoglobinopathies
Part II: thalassaemias
by Fabrizia Urbinati, Catherine Madigan and Punam Malik
Abstract
and features
Published 9th May
2006
Pathophysiology
and therapy for haemoglobinopathies
Part I: sickle cell disease
by Catherine Madigan and Punam Malik
Abstract
and features
The fragile
X syndrome: exploring its molecular basis and seeking a treatment
by Barbara Bardoni, Laetitia Davidovic, Mounia Bensaid and Edouard W.
Khandjian
Abstract
and features
New insights into the functions of anthrax toxin
by David
J. Banks, Sabrina C. Ward and Kenneth A. Bradley
Abstract
and features
Insights into the immunopathogenesis of malaria using mouse models
by Tracey J. Lamb, Douglas E. Brown, Alexandre J. Potocnik and Jean Langhorne
Abstract
and features
DNA-damage
response pathways triggered by viral replication
by Alison
Sinclair, Sarah Yarranton and Celine Schelcher
Abstract
and features
Role for
GLUT1 in diabetic glomerulosclerosis
by Charles
W. Heilig, Frank C. Brosius III and Carol Cunningham
Abstract
and features
Preeclampsia:
current understanding of the molecular basis of vascular dysfunction
by Sowndramalingam
Sankaralingam, Ivan A. Arenas, Manoj M. Lalu and Sandra T. Davidge
Abstract
and features
Molecular
pathogenesis of autosomal dominant polycystic kidney disease
by Bradley
K. Yoder, Sharon Mulroy, Hannah Eustace, Catherine Boucher and Richard Sandford
Abstract
and features
RNA repair
for haemophilia A
by Hengjun Chao and Christopher E. Walsh
Abstract and features
2005
T-cell
signalling and immune system disorders
by Beverley
Wilkinson, Jocelyn S. Downey and Christopher E. Rudd
Abstract
and features
Molecular
pathogenesis of rheumatic fever and rheumatic heart disease
by Luiza
Guilherme, Kellen Faé, Sandra E. Oshiro and Jorge Kalil
Abstract
and features
Evolving
paradigms in the pathogenesis of HIV-1-associated dementia
by Tracy
Fischer-Smith and Jay Rappaport
Abstract
and features
Immunopathogenesis
of Pneumocystis carinii pneumonia
by Francis
Gigliotti and Terry W. Wright
Abstract
and features
Current
molecular understanding of Axenfeld–Rieger syndrome
by Tord
A. Hjalt and Elena V. Semina
Abstract
and features
TIMP3
mutation in Sorsby’s fundus dystrophy: molecular insights
by Zheng
Li, Michael P. Clarke, Michael D. Barker and Norman McKie
Abstract
and features
HLA,
CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?
by Oliver Brand, Stephen Gough and Joanne Heward
Abstract
and features
The tumour
necrosis factor receptor-associated periodic syndrome: current concepts
by Silvia
Stojanov and Michael F. McDermott
Abstract
and features
Relaxin
and the extracellular matrix: molecular mechanisms of action and implications
for cardiovascular disease
by Jonathan
T. McGuane and Laura J. Parry
Abstract
and features
Pathways
to improving skin regeneration
by Christelle
Adolphe and Brandon Wainwright
Abstract
and features
Human embryonic
stem cells: biology and clinical implications
by Louise
A. Hyslop, Lyle Armstrong, Miodrag Stojkovic and Majlinda Lako
Abstract
and features
Sperm-based
contraceptive vaccines: current status, merits and development
by Anil
Suri
Abstract
and features
Molecular
medicine of gastric adenocarcinomas
by Gisela
Keller, Heinz Höfler and Karl-Friedrich Becker
Abstract
and features
Molecular
therapeutic targets in rheumatoid arthritis
by Sandra
M. Sacre, Evangelos Andreakos, Peter Taylor, Marc Feldmann and Brian M.
Foxwell
Abstract
and features
Molecular
and therapeutic aspects of varicella–zoster virus infection
by Mark Quinlivan and Judith Breuer
Abstract
and features
Prader–Willi
syndrome: clinical genetics, cytogenetics and molecular biology
by Douglas C. Bittel and Merlin G. Butler
Abstract
and features
Cellular
and molecular mechanisms that underlie Entamoeba histolytica pathogenesis:
prospects for intervention
by Richard C. Laughlin and Lesly A. Temesvari
Abstract
and features
Regulation
of pro-inflammatory signalling networks by ubiquitin: identification of
novel targets for anti-inflammatory drugs
by Paul C. Evans
Abstract
and features
Nesprins:
intracellular scaffolds that maintain cell architecture and coordinate cell
function?
by Derek T. Warren, Qiuping Zhang, Peter L. Weissberg and Catherine M. Shanahan
Abstract
and features
The phosphoinositide
3-kinase pathway and cancer
by David Stokoe
Abstract
and features
The genetic
epidemiology of human primary osteoarthritis: current status
by John Loughlin
Abstract
and features
Pathogenesis
of Wegener’s granulomatosis: current concepts
by Pasha Sarraf and Michael C. Sneller
Abstract
and features
Inflammation
and atherosclerosis in rheumatoid arthritis
by Robert J. Stevens, Karen M.J. Douglas, Athanasios N. Saratzis and George
D. Kitas
Abstract
and features
PARP inhibitors
for cancer therapy
by Nicola J. Curtin
Abstract
and features
Targeting
the molecular basis for tumour hypoxia
by Veronica A. Carroll and Margaret Ashcroft
Abstract
and features
Chronic
tendon pathology: molecular basis and therapeutic implications
by Graham
Riley
Abstract
and features
Multiple
sclerosis: MHC associations and therapeutic implications
by Samantha
Holmes, Manuel A. Friese, Christian Siebold, E. Yvonne Jones, John Bell
and Lars Fugger
Abstract
and features
The
prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
by Neil Sheppard and Quentin Sattentau
Abstract and features
PPARg
as a metabolic regulator: insights from genomics and pharmacology
by David
B. Savage
Abstract and features
2004
Dyskeratosis
congenita: molecular insights into telomerase function, ageing and cancer
by Anna
Marrone and Inderjeet Dokal
Abstract and features
Retinoids:
potential in cancer prevention and therapy
by Nicole
Clarke, Pierre Germain, Lucia Altucci and Hinrich Gronemeyer
Abstract and features
Chronic
idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications
for therapy
by Per-Ola
Andersson and Hans Wadenvik
Abstract and features
Infectious
mononucleosis and Epstein–Barr virus
by Eleni-Kyriaki
Vetsika and Margaret Callan
Abstract and features
SOCS proteins
in T helper cell differentiation: implications for allergic disorders?
by Hiromasa
Inoue and Masato Kubo
Abstract and features
Lithium
neuroprotection: molecular mechanisms and clinical implications
by Michael
K. Rowe and De-Maw Chuang
Abstract and features
Ebola virus:
new insights into disease aetiopathology and possible therapeutic interventions
by Thomas W. Geisbert and Lisa E. Hensley
Abstract and features
Tumour-targeted
drug and gene delivery: principles and concepts
by Jim
Cassidy and Andreas G. Schätzlein
Abstract and features
Genetic
manipulation of drug sensitivity in haematopoietic cells
by Thomas
Southgate and Leslie J. Fairbairn
Abstract and features
The discovery
and role of ADAM33, a new candidate gene for asthma
by John
W. Holloway, Donna E. Davies, Robert Powell, Hans-Michael Haitchi, Tim P.
Keith and Stephen T. Holgate
Abstract and features
Parvovirus
vectors: use and optimisation in cancer gene therapy
by Boris
Blechacz and Stephen J. Russell
Abstract and features
Diabetes
and retinal vascular disorders: role of the renin–angiotensin system
by Jennifer L. Wilkinson-Berka
Abstract and features
Interactions
between Neisseria meningitidis and human cells that promote colonisation
and disease
by Anne
Corbett, Rachel Exley, Sandrine Bourdoulous and Christoph M. Tang
Abstract and features
Gene therapy
for severe combined immune deficiency
by Waseem
Qasim, H. Bobby Gaspar and Adrian J. Thrasher
Abstract and features
Critical
evaluation of p53 as a prognostic marker in ovarian cancer
by Jacqueline
Hall, Jim Paul and Robert Brown
Abstract and features
Human pregnancy:
the role of chemokine networks at the fetal–maternal interface
by Kristy
Red-Horse, Penelope M. Drake and Susan J. Fisher
Abstract
and features
Regulatory
SNPs in complex diseases: their identification and functional validation
by Ludmila
Prokunina and Marta E. Alarcón-Riquelme
Abstract and features
Can genital-tract
human papillomavirus infection and cervical cancer be prevented with a vaccine?
by Joakim
Dillner and Darron R. Brown
Abstract and features
Herpetic
eye disease: immunopathogenesis and therapeutic measures
by Shilpa
Deshpande, Kaustuv Banerjee, Partha Sarathi Biswas and Barry T. Rouse
Abstract and features
BAG-1 in
carcinogenesis
by Adam
Sharp, Simon J. Crabb, Paul A. Townsend, Ramsey I. Cutress, Matthew Brimmell,
Xiu-hong Wang and Graham Packham
Abstract and features
Primary
pulmonary hypertension: molecular basis and potential for therapy
by Nung
Rudarakanchana and Nicholas W. Morrell
Abstract and features
Gene therapy
for Parkinson’s disease
by Patricia
A. Lawlor and Matthew J. During
Abstract and features
Sepsis:
molecular mechanisms underlying lipopolysaccharide recognition
by
Martha
Triantafilou and Kathy Triantafilou
Abstract and features
SH2 domains:
role, structure and implications for molecular medicine
by
Gabriel
Waksman, Sangaralingam Kumaran and Olga Lubman
Abstract and features
Lyme borreliosis
(Lyme disease): molecular and cellular pathobiology and prospects for prevention,
diagnosis and treatment
by
Paul
G. Auwaerter, John Aucott and J. Stephen Dumler
Abstract and features
Molecular
aetiology of primary hyperoxaluria and its implications for clinical management
by Christopher
J. Danpure and Gill Rumsby
Abstract and features
2003
Novel concepts
in excitotoxic neurodegeneration after stroke
by
Michelle
M. Aarts, Mark Arundine and Michael Tymianski
Abstract and features
Herpes simplex
virus latency
by
Robin Lachmann
Abstract and features
Molecular
pathogenesis of chronic myeloid leukaemia
by Duncan L. Smith, John Burthem and Anthony D. Whetton
Abstract and features
Hepatocellular
carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis
by
Mónica
Anzola and Juan José Burgos
Abstract and features
Tissue microarray
(TMA) applications: implications for molecular medicine
by
Ronald
Simon and Guido Sauter
Abstract and features
Molecular
mechanisms of learning and memory
by
Jane
Dunning and Matthew J. During
Abstract and features
Molecular
mechanisms by which dietary isoflavones potentially prevent atherosclerosis
by Aedin Cassidy, Sonia de Pascual Teresa and Gerald Rimbach
Abstract and features
Metalloproteinases
and their inhibitors in angiogenesis
by Marc A. Lafleur, Madeleine M. Handsley and Dylan R. Edwards
Abstract and features
Nonviral
gene delivery: techniques and implications for molecular medicine
by Alan
L. Parker, Christopher Newman, Simon Briggs, Leonard Seymour and Paul J.
Sheridan
Abstract and features
Repeat expansion
and autosomal dominant neurodegenerative disorders: consensus and controversy
by Dobrila
D. Rudnicki and Russell L. Margolis
Abstract and features
Huntington’s
disease: molecular basis of neurodegeneration
by David
C. Rubinsztein and Jenny Carmichael
Abstract and features
Toll-like
receptors and intestinal defence: molecular basis and therapeutic implications
by Elke Cario
Abstract and features
A multifaceted
role for ATM in genome maintenance
by
Tej K. Pandita
Abstract and features
Cobalamin
transport proteins and their cell-surface receptors
by
Bellur Seetharam and Raghunatha R. Yammani
Abstract and features
Gene therapy
for cancer and metastatic disease
by
Susan B. Kesmodel and Francis R. Spitz
Abstract and features
Innate immunity
and brain inflammation: the key role of complement
by
Karen Francis, Johan van Beek, Cecile Canova, Jim W. Neal and Philippe Gasque
Abstract and features
Grb7-based
molecular therapeutics in cancer
by
Stephanie C. Pero, Roger J. Daly and David N. Krag
Abstract and features
Genetic
factors underlying prostate cancer
by
Jian-Hua Luo and Yan Ping Yu
Abstract and features
Transgenic
mice carrying yeast artificial chromosomes
by
Kenneth R. Peterson
Abstract and features
Modern therapeutic
approaches in Parkinson’s disease
by
Simon J.G. Lewis, Maeve A. Caldwell and Roger A. Barker
Abstract and features
Anti-p53-directed
immunotherapy of malignant disease
by
Matthias Theobald and Rienk Offringa
Abstract and features
Skin repair
and scar formation: the central role of TGF-b
by
Steven R. Beanes, Catherine Dang, Chia Soo and Kang Ting
Abstract and features
Cyclooxygenase
isoforms and atherosclerosis
by
Orina Belton and Desmond J. Fitzgerald
Abstract and features
The genetics
of nontuberculous mycobacterial infection
by
Melanie Newport
Abstract and features
MHC-based
vaccination approaches: progress and perspectives
by
Narinder K. Mehra and Gurvinder Kaur
Abstract and features
Molecular basis of hepat